MX2017004839A - Composiciones de acidos grasos monoinsaturados y uso para tratar la ateroesclerosis. - Google Patents

Composiciones de acidos grasos monoinsaturados y uso para tratar la ateroesclerosis.

Info

Publication number
MX2017004839A
MX2017004839A MX2017004839A MX2017004839A MX2017004839A MX 2017004839 A MX2017004839 A MX 2017004839A MX 2017004839 A MX2017004839 A MX 2017004839A MX 2017004839 A MX2017004839 A MX 2017004839A MX 2017004839 A MX2017004839 A MX 2017004839A
Authority
MX
Mexico
Prior art keywords
monounsaturated fatty
compositions
fatty acid
acid compositions
atherosclerosis
Prior art date
Application number
MX2017004839A
Other languages
English (en)
Spanish (es)
Inventor
M Burke John
Original Assignee
Burke & Boyer Nyc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burke & Boyer Nyc filed Critical Burke & Boyer Nyc
Publication of MX2017004839A publication Critical patent/MX2017004839A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2017004839A 2014-10-15 2015-10-14 Composiciones de acidos grasos monoinsaturados y uso para tratar la ateroesclerosis. MX2017004839A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462064207P 2014-10-15 2014-10-15
PCT/US2015/055504 WO2016061207A1 (en) 2014-10-15 2015-10-14 Monounsaturated fatty acid compositions and use for treating atherosclerosis

Publications (1)

Publication Number Publication Date
MX2017004839A true MX2017004839A (es) 2017-10-12

Family

ID=55747261

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004839A MX2017004839A (es) 2014-10-15 2015-10-14 Composiciones de acidos grasos monoinsaturados y uso para tratar la ateroesclerosis.

Country Status (8)

Country Link
US (1) US9808437B2 (cg-RX-API-DMAC7.html)
EP (1) EP3206677A4 (cg-RX-API-DMAC7.html)
JP (2) JP6840671B2 (cg-RX-API-DMAC7.html)
CN (2) CN113244206A (cg-RX-API-DMAC7.html)
BR (1) BR112017007754B1 (cg-RX-API-DMAC7.html)
CA (1) CA2963980A1 (cg-RX-API-DMAC7.html)
MX (1) MX2017004839A (cg-RX-API-DMAC7.html)
WO (1) WO2016061207A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7602315B2 (ja) * 2018-10-16 2024-12-18 株式会社ニッスイ 血清中tmao低減用組成物
EP4017484A4 (en) * 2019-08-21 2022-10-19 Burke & Boyer, Inc. MONOUNSATURATED FATTY ACID COMPOSITION AND USE TO TREAT FAT LIVER DISEASE
US20240263200A1 (en) * 2021-06-11 2024-08-08 Nourish Ingredients Pty Ltd Production of saturated fats in microbes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
US6183796B1 (en) * 1999-09-20 2001-02-06 Lipotech Partners Limited Partnership Monounsaturated fatty acid compositions and method of making
EP2001484A4 (en) * 2006-03-22 2010-04-21 Harvard College METHOD AND COMPOSITIONS FOR TREATING HYPERCHOLESTERINEMIA AND ATHEROSCLEROSIS
US20090311367A1 (en) 2008-06-17 2009-12-17 Perry Stephen C Dietary Supplement
ES2653940T3 (es) * 2009-01-05 2018-02-09 Calanus As Composición de aceite biológico, formulaciones que comprenden la composición de aceite y el uso de las mismas para la prevención o el tratamiento de enfermedades cardiovasculares
JP6206937B2 (ja) * 2010-10-08 2017-10-04 和久 前田 マッサージ施療による経皮投与用の血流依存性血管拡張反応改善剤及び血糖値低下剤、並びに生体用貼付シート
KR20140010126A (ko) 2011-03-03 2014-01-23 터서스 파마수티칼 엘엘씨 C16:1n7-팔미톨리에이트를 포함하는 조성물들 및 방법들
ITMI20111284A1 (it) * 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
WO2014054048A1 (en) * 2012-10-01 2014-04-10 Dow Global Technologies Llc Triglyceride based, low viscosity, high flash point dielectric fluids

Also Published As

Publication number Publication date
CN106794165A (zh) 2017-05-31
WO2016061207A1 (en) 2016-04-21
CA2963980A1 (en) 2016-04-21
CN113244206A (zh) 2021-08-13
JP2017532381A (ja) 2017-11-02
EP3206677A4 (en) 2018-04-25
JP2020182497A (ja) 2020-11-12
US20170216237A1 (en) 2017-08-03
EP3206677A1 (en) 2017-08-23
BR112017007754A2 (pt) 2018-08-28
BR112017007754B1 (pt) 2023-04-11
JP6840671B2 (ja) 2021-03-10
US9808437B2 (en) 2017-11-07

Similar Documents

Publication Publication Date Title
ZA201908449B (en) Novel modified acid compositions as alternatives to conventional acids in the oil and gas industry
MX384370B (es) Lípido que comprende ácidos grasos poliinsaturados de cadena larga.
NZ702325A (en) Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
MX384154B (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados.
DK3728509T3 (en) Novel modified acid compositions as alternatives to conventional acids in the oil and gas industry
EP3789476C0 (en) METHOD FOR PRODUCING VERY LONG CHAIN POLYUNSATURATED FATTY ACIDS MADE FROM NATURAL OILS AND NUTRACEUTICAL COMPOSITIONS OBTAINED.
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
TW201613488A (en) Nutritional compositions containing oil blends and uses thereof
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
NZ747847A (en) Lipid compositions
WO2012148929A3 (en) Disorders implicating pufa oxidation
BR112015016529A2 (pt) processo de separação cromatográfica, produto pufa, e, composição
HK1209286A1 (en) Removal of undesired components from oil compositions
MY181997A (en) Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
MX391057B (es) Proceso para aumentar la estabilidad de una composicion que comprende acidos grasos omega-6 poliinsaturados.
MX2017016320A (es) Composiciones nutricionales y metodos para promover el desarrollo cognitivo.
MX2013008743A (es) Uso de al menos un coproducto de la industria de refinacion de aceite vegetal para la obtencion de un producto de aceite vegeal insaponificable purificado total.
MX2015011767A (es) Composiciones de aceite crudo de algas.
WO2014165190A3 (en) Compositions comprising docosapentaenoic acid and methods of use
MX2017004839A (es) Composiciones de acidos grasos monoinsaturados y uso para tratar la ateroesclerosis.
MX355668B (es) Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.
BR112016025931A8 (pt) composição de barra de sabão extrudada, barra e método para intensificar a transparência das barras de sabão
NZ734149A (en) Millicapsule formulations comprising polyunsaturated free fatty acids
PH12017500203A1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair